Oral cephalosporins for use in a parenteral-to-oral switch programme
- 1 March 1995
- journal article
- Published by Springer Nature in Infection
- Vol. 23 (S2) , S87-S90
- https://doi.org/10.1007/bf01742991
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antibiotic guidelines and antibiotic utilization in Dutch hospitalsJournal of Antimicrobial Chemotherapy, 1993
- The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporinsJournal of Antimicrobial Chemotherapy, 1990
- Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteersAntimicrobial Agents and Chemotherapy, 1990
- In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1990
- Absolute Bioavailability of Cefixime in ManThe Journal of Clinical Pharmacology, 1988
- In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefiximeThe Pediatric Infectious Disease Journal, 1987
- Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and childrenJournal of Antimicrobial Chemotherapy, 1982
- Antimicrobial usage in forty-three hospitals in EnglandJournal of Antimicrobial Chemotherapy, 1982
- Pharmacokinetics of cefotaxime in normal human volunteersJournal of Antimicrobial Chemotherapy, 1980
- HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1979